Evidence map›Paper›PMID 41461870›Full record

ArticleScientific reports2025

Assessment of gamma and neutron shielding features of Se

Nisha Kumari, Vishnu Saraswat, Shiv Kumar Pal, Ishu Sharma, Z Y Khattari, Neeraj Mehta

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Increased risk of frailty and falls in older persons with hearing loss.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nisha KumariDepartment of Physics, Institute of Science, Banaras Hindu University, Varanasi, 221005, India.
Vishnu SaraswatDepartment of Physics, Institute of Science, Banaras Hindu University, Varanasi, 221005, India.
Shiv Kumar PalDepartment of Physics, Institute of Science, Banaras Hindu University, Varanasi, 221005, India.
Ishu SharmaDepartment of Physics, Amity University, Dubai, United Arab Emirates.
Z Y KhattariDepartment of Physics, Faculty of Science, The Hashemite University, P. O. Box 330127, Zarqa, 13133, Jordan.
Neeraj MehtaDepartment of Physics, Institute of Science, Banaras Hindu University, Varanasi, 221005, India. dr_neeraj_mehta@yahoo.co.in.

Funding

Amity University, Dubai FRG24-C5-Ishu
6 · The paper itself

Abstract

The ternary transition-metal chalcogenide system possesses high potential in various fields of science and technology. The present report highlights a comparative study on the high-energy radiation shielding properties of transition metals as chemical modifiers in the Se80 − yTe20My (M = Fe, Co, Ni, Cu, y = 0 and 2) chalcogenide series, spanning a broad photon energy range of 15 keV to 15 MeV. The radiation shielding capability of the studied materials against high-energy radiation, such as X-rays and gamma rays, was evaluated using Phy-X/PSD software and experimentally validated. Various parameters essential for evaluating radiation shielding performance were investigated, including MFP, HVL, LAC, MAC, Zeff, Neff, Zeq, RPE, TF, EABF, EBF, and FNRCS (ΣR). Among the studied samples, the Fe incorporated sample (STFe) exhibited the most effective shielding performance. At 0.015 MeV, it recorded the highest LAC (~ 413.87 cm⁻¹) and a MAC of 87.498 cm²/g, values significantly higher than those of standard shielding materials. STFe showed the lowest HVL and MFP at 0.015 MeV, confirming its strong gamma-ray shielding. It also had the highest FNRCS (0.076 cm⁻¹), indicating excellent neutron protection. Its excellent performance arises from its higher density.

Indexed as

AttenuationChalcogenidesDensityRadiation shieldingTransition metals

Identifiers

PMID41461870
PMCPMC12855298

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.